Cargando…
A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis
BACKGROUND: Tumor necrosis factor-like weak inducer of apoptosis (Tnfsf12; TWEAK) and its receptor Fibroblast growth factor-inducible 14 (Tnfrsf12a; Fn14) participate in the inflammatory response associated with vascular remodeling. However, the functional effect of TWEAK on vascular smooth muscle c...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712059/ https://www.ncbi.nlm.nih.gov/pubmed/31395500 http://dx.doi.org/10.1016/j.ebiom.2019.07.072 |
_version_ | 1783446613550694400 |
---|---|
author | Méndez-Barbero, Nerea Gutierrez-Muñoz, Carmen Madrigal-Matute, Julio Mínguez, Pablo Egido, Jesús Michel, Jean-Baptiste Martín-Ventura, Jose L. Esteban, Vanesa Blanco-Colio, Luis M. |
author_facet | Méndez-Barbero, Nerea Gutierrez-Muñoz, Carmen Madrigal-Matute, Julio Mínguez, Pablo Egido, Jesús Michel, Jean-Baptiste Martín-Ventura, Jose L. Esteban, Vanesa Blanco-Colio, Luis M. |
author_sort | Méndez-Barbero, Nerea |
collection | PubMed |
description | BACKGROUND: Tumor necrosis factor-like weak inducer of apoptosis (Tnfsf12; TWEAK) and its receptor Fibroblast growth factor-inducible 14 (Tnfrsf12a; Fn14) participate in the inflammatory response associated with vascular remodeling. However, the functional effect of TWEAK on vascular smooth muscle cells (VSMCs) is not completely elucidated. METHODS: Next generation sequencing-based methods were performed to identify genes and pathways regulated by TWEAK in VSMCs. Flow-citometry, wound-healing scratch experiments and transwell migration assays were used to analyze VSMCs proliferation and migration. Mouse wire injury model was done to evaluate the role of TWEAK/Fn14 during neointimal hyperplasia. FINDINGS: TWEAK up-regulated 1611 and down-regulated 1091 genes in VSMCs. Using a gene-set enrichment method, we found a functional module involved in cell proliferation defined as the minimal network connecting top TWEAK up-regulated genes. In vitro experiments in wild-type or Tnfrsf12a deficient VSMCs demonstrated that TWEAK increased cell proliferation, VSMCs motility and migration. Mechanistically, TWEAK increased cyclins (cyclinD1), cyclin-dependent kinases (CDK4, CDK6) and decreased cyclin-dependent kinase inhibitors (p15(lNK4B)) mRNA and protein expression. Downregulation of p15(INK4B) induced by TWEAK was mediated by mitogen-activated protein kinase ERK and Akt activation. Tnfrsf12a or Tnfsf12 genetic depletion and pharmacological intervention with TWEAK blocking antibody reduced neointimal formation, decreasing cell proliferation, cyclin D1 and CDK4/6 expression, and increasing p15(INK4B) expression compared with wild type or IgG-treated mice in wire-injured femoral arteries. Finally, immunohistochemistry in human coronary arteries with stenosis or in-stent restenosis revealed high levels of Fn14, TWEAK and PCNA in VSMCs enriched areas of the neointima as compared with healthy coronary arteries. INTERPRETATION: Our data define a major role of TWEAK/Fn14 in the control of VSMCs proliferation and migration during neointimal hyperplasia after wire injury in mice, and identify TWEAK/Fn14 as a potential target for treating in-stent restenosis. FUND: ISCiii-FEDER, CIBERCV and CIBERDEM. |
format | Online Article Text |
id | pubmed-6712059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-67120592019-08-29 A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis Méndez-Barbero, Nerea Gutierrez-Muñoz, Carmen Madrigal-Matute, Julio Mínguez, Pablo Egido, Jesús Michel, Jean-Baptiste Martín-Ventura, Jose L. Esteban, Vanesa Blanco-Colio, Luis M. EBioMedicine Research paper BACKGROUND: Tumor necrosis factor-like weak inducer of apoptosis (Tnfsf12; TWEAK) and its receptor Fibroblast growth factor-inducible 14 (Tnfrsf12a; Fn14) participate in the inflammatory response associated with vascular remodeling. However, the functional effect of TWEAK on vascular smooth muscle cells (VSMCs) is not completely elucidated. METHODS: Next generation sequencing-based methods were performed to identify genes and pathways regulated by TWEAK in VSMCs. Flow-citometry, wound-healing scratch experiments and transwell migration assays were used to analyze VSMCs proliferation and migration. Mouse wire injury model was done to evaluate the role of TWEAK/Fn14 during neointimal hyperplasia. FINDINGS: TWEAK up-regulated 1611 and down-regulated 1091 genes in VSMCs. Using a gene-set enrichment method, we found a functional module involved in cell proliferation defined as the minimal network connecting top TWEAK up-regulated genes. In vitro experiments in wild-type or Tnfrsf12a deficient VSMCs demonstrated that TWEAK increased cell proliferation, VSMCs motility and migration. Mechanistically, TWEAK increased cyclins (cyclinD1), cyclin-dependent kinases (CDK4, CDK6) and decreased cyclin-dependent kinase inhibitors (p15(lNK4B)) mRNA and protein expression. Downregulation of p15(INK4B) induced by TWEAK was mediated by mitogen-activated protein kinase ERK and Akt activation. Tnfrsf12a or Tnfsf12 genetic depletion and pharmacological intervention with TWEAK blocking antibody reduced neointimal formation, decreasing cell proliferation, cyclin D1 and CDK4/6 expression, and increasing p15(INK4B) expression compared with wild type or IgG-treated mice in wire-injured femoral arteries. Finally, immunohistochemistry in human coronary arteries with stenosis or in-stent restenosis revealed high levels of Fn14, TWEAK and PCNA in VSMCs enriched areas of the neointima as compared with healthy coronary arteries. INTERPRETATION: Our data define a major role of TWEAK/Fn14 in the control of VSMCs proliferation and migration during neointimal hyperplasia after wire injury in mice, and identify TWEAK/Fn14 as a potential target for treating in-stent restenosis. FUND: ISCiii-FEDER, CIBERCV and CIBERDEM. Elsevier 2019-08-05 /pmc/articles/PMC6712059/ /pubmed/31395500 http://dx.doi.org/10.1016/j.ebiom.2019.07.072 Text en © 2019 The Authors. Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research paper Méndez-Barbero, Nerea Gutierrez-Muñoz, Carmen Madrigal-Matute, Julio Mínguez, Pablo Egido, Jesús Michel, Jean-Baptiste Martín-Ventura, Jose L. Esteban, Vanesa Blanco-Colio, Luis M. A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis |
title | A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis |
title_full | A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis |
title_fullStr | A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis |
title_full_unstemmed | A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis |
title_short | A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis |
title_sort | major role of tweak/fn14 axis as a therapeutic target for post-angioplasty restenosis |
topic | Research paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712059/ https://www.ncbi.nlm.nih.gov/pubmed/31395500 http://dx.doi.org/10.1016/j.ebiom.2019.07.072 |
work_keys_str_mv | AT mendezbarberonerea amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT gutierrezmunozcarmen amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT madrigalmatutejulio amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT minguezpablo amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT egidojesus amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT micheljeanbaptiste amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT martinventurajosel amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT estebanvanesa amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT blancocolioluism amajorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT mendezbarberonerea majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT gutierrezmunozcarmen majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT madrigalmatutejulio majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT minguezpablo majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT egidojesus majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT micheljeanbaptiste majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT martinventurajosel majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT estebanvanesa majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis AT blancocolioluism majorroleoftweakfn14axisasatherapeutictargetforpostangioplastyrestenosis |